Back
FONAR Corp. 10K Form
Sell
42
FONR
FONAR Corp.
Last Price:
$14.56
Seasonality Move:
5.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | FONR/FONAR Corp. Quarterly |
| 2024-02-14 | 10Q | FONR/FONAR Corp. Quarterly |
| 2023-11-14 | 10Q | FONR/FONAR Corp. Quarterly |
| 2023-05-15 | 10Q | FONR/FONAR Corp. Quarterly |
| 2023-02-14 | 10Q | FONR/FONAR Corp. Quarterly |
| 2022-11-14 | 10Q | FONR/FONAR Corp. Quarterly |
Receive FONR News And Ratings
See the #1 stock for the next 7 days that we like better than FONR
FONR Financial Statistics
Sales & Book Value
| Annual Sales: | $104.4M |
|---|---|
| Cash Flow: | $-636K |
| Price / Cash Flow: | 13.2 |
| Annual Sales: | $27.87 |
| Price / Book: | 0.52 |
Profitability
| EPS (TTM): | 1.10620 |
|---|---|
| Net Income (TTM): | $9.3M |
| Gross Margin: | $42.9M |
| Return on Equity: | 5.84% |
| Return on Assets: | 4.36% |
FONAR Corp. Earnings Forecast
Key FONAR Corp. Financial Ratios
-
The Gross Profit Margin over the past 37 years for FONR is 41.12%.
-
The Selling, General & Administrative Expenses for FONR have been equal to 28.49% of Gross Profit Margin.
-
The Research & Development expenses have been 1.51% of Revenue.
-
The Interest Expense is 0.24% of Operating Income.
-
The Net Earning history of FONR is 10.23% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 19 years.
FONAR Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | FONR |
| CUSIP: | 344437 |
| Website: | fonar.com |
Debt
| Debt-to-Equity Ratio: | 0.23 |
|---|---|
| Current Ratio: | 8.63 |
| Quick Ratio: | 9.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.74 |
|---|---|
| Forward P/E Ratio: | 0 |
FONR Technical Analysis vs Fundamental Analysis
Sell
42
FONAR Corp. (FONR)
is a Sell
Is FONAR Corp. a Buy or a Sell?
-
FONAR Corp. stock is rated a SellThe current FONAR Corp. [FONR] share price is $14.46. The Score for FONR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.